Recent investigations have suggested an oncogenic role of TET1 in solid cancers [9,10,11] and its involvement in the maintenance of cancer stem cells (CSCs) in prostate cancer [12], triple-negative breast cancer (TNBC) [13,14], and endometrial cancer [15]. The gene discussed is TET1; the disease is cancer.